By Roger-Marc Nicoud, Ypso-Fcato and Thierry Bastogne, CYBERnano
Regulatory bodies, including the FDA and EMA, are strongly promoting the implementation of QbD: a science and risk-based approach to drug development and manufacturing to increase the success rate, process robustness and eventually product quality.
In the meantime, different practitioners are a bit...
Sign In or Register